HIV Prevention Peer Navigation for Justice Involved Women (kINSHIP)
kINSHIP: Peer Navigators Addressing INtersectional Stigma to Improve HIV Prevention Among Criminal-justice Involved Women
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Emily Dauria, PhD, MPH
- Phone Number: (628) 206-8306
- Email: efd16@pitt.edu
Study Contact Backup
- Name: Priyanka Kulkarni
- Email: priyanka.kulkarni2@ucsf.edu
Study Locations
-
-
California
-
San Francisco, California, United States, 94110
- University of California San Francisco
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Women in San Francisco Adult Probation, ages 18-49 will be eligible if they:
- self-identify as HIV-negative;
- endorse risk behaviors in the past 6 months that call for consideration of PrEP per the Centers of Disease Control and Prevention risk indices;
- are English-Speaking.
Exclusion Criteria:
- Self-reported HIV infection;
- already on PrEP;
- observable cognitive/developmental delays or severe mental illness that would interfere with consent or participation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Active-kINSHIP navigation intervention
kINSHIP is a peer-led navigator intervention to address intersectional stigma and improve PrEP treatment initiation and engagement for justice-involved women.
The key components of the kINSHIP intervention are to: 1) increase social support; 2) increase self-efficacy in accessing PrEP services; 3) enhance access to healthcare services; 4) improve adaptive coping skills to manage experiences of intersectional stigma.
|
kINSHIP is a peer-led navigator intervention to address intersectional stigma and improve PrEP treatment initiation and engagement for justice-involved women.
The key components of the kINSHIP intervention are to: 1) increase social support; 2) increase self-efficacy in accessing PrEP services; 3) enhance access to healthcare services; 4) improve adaptive coping skills to manage experiences of intersectional stigma.
|
|
Active Comparator: Control-Standard Care
The control arm will be standard-of-care, which is as-needed case management for justice-involved women.
|
The control arm will be standard-of-care, which is as-needed case management for justice-involved women.
The goals of case management services are to reduce recidivism, mitigate behavioral challenges, strengthen public safety, and build self-sufficiency skills.
Case managers refer clients to appropriate services in the community (e.g., housing, food).
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Linkage to PrEP Services
Time Frame: 4 months post enrollment
|
The primary outcome of PrEP linkage will be attendance at a PrEP services appointment, verified by medical records.
|
4 months post enrollment
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accepted PrEP Referral
Time Frame: 4 months post enrollment
|
Self-report
|
4 months post enrollment
|
|
Time to PrEP Linkage
Time Frame: 4 months post enrollment
|
Reported by via medical record.
|
4 months post enrollment
|
|
Accepted PrEP Prescription
Time Frame: 4 months post enrollment
|
Self-report.
|
4 months post enrollment
|
|
PrEP Initiation
Time Frame: 4 months post enrollment
|
Self-report.
|
4 months post enrollment
|
|
PrEP Adherence
Time Frame: 4 months post enrollment
|
Self-report.
|
4 months post enrollment
|
|
PrEP Persistence
Time Frame: 4 months post enrollment
|
Self-report.
|
4 months post enrollment
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Emily Dauria, PhD, MPH, University of California, San Francisco
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Blood-Borne Infections
- Urogenital Diseases
- Genital Diseases
- Mental Disorders
- Immune System Diseases
- Infections
- RNA Virus Infections
- Virus Diseases
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Chemically-Induced Disorders
- Behavior
- Social Behavior
- HIV Infections
- Substance-Related Disorders
- Social Stigma
Other Study ID Numbers
Other Study ID Numbers
- 20-30358
- R34DA050480 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.